Journal List > Allergy Asthma Respir Dis > v.6(2) > 1104570

Yon, Min, Ha, Jee, Jung, Lee, Sheen, and Han: Clinical characteristics and genetic variation in respiratory syncytial virus isolated from infants hospitalized due to acute bronchiolitis in Korea during winter season 2016–2017

Abstract

Purpose

Circulating patterns of predominant respiratory syncytial virus (RSV) genotypes in the community may be helpful in understanding molecular epidemiology and predicting future outbreaks of the RSV genotype. We investigated the association of genetic variations in RSV with acute severe bronchiolitis in infants.

Methods

We reviewed medical records of infants younger than 1 year of age hospitalized due to acute bronchiolitis between November 2016 and February 2017. Subjects were classified as severe or mild based on the use of mechanical or noninvasive ventilation. The associations between severity of the disease, sex, age at admission, oxygen saturation at admission and laboratory test results were analyzed. RSV sequence analysis was performed in the severe group.

Results

Among 114 infants, 80 underwent respiratory viral polymerase chain reaction using nasopharyngeal swab; of these, 53 (66.3%) showed positive for RSV. Of the 53 RSV-positive samples, 9 were categorized as the severe group and 44 were categorized as the mild group. Male sex, young age, longer duration of admission, minimum SaO2 at admission and bronchiolitis severity score were significantly correlated with disease severity in the severe group than in the mild group (all variables, P<0.001). Phylogenetic and sequence analysis in the severe group revealed 8 RSV-A, ON1 genotype and 1 RSV-B, BA4 genotype.

Conclusion

Phylogenetic types of RSV in subjects of the severe group were RSV-A, ON1 genotype or RSV-B, BA4 genotype which were prevalent in the Korean community at the same time. Our study showed that disease severity was not significantly associated with RSV genotypic evolution or antigenic drift in Korea during winter season 2016–17.

REFERENCES

1. Blount RE Jr, Morris JA, Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med. 1956; 92:544–9.
2. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol. 1998; 79(Pt 9):2221–9.
crossref
3. Esposito S, Piralla A, Zampiero A, Bianchini S, Di Pietro G, Scala A, et al. Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in Five consecutive winter seasons. PLoS One. 2015; 10:e0129369.
crossref
4. Kim YJ, Kim DW, Lee WJ, Yun MR, Lee HY, Lee HS, et al. Rapid replacement of human respiratory syncytial virus A with the ON1 genotype having 72 nucleotide duplication in G gene. Infect Genet Evol. 2014; 26:103–12.
crossref
5. Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010; 125:342–9.
crossref
6. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis. 1992; 145:106–9.
crossref
7. Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med. 2014; 22:23.
crossref
8. da Silva LH, Spilki FR, Riccetto AG, de Almeida RS, Baracat EC, Arns CW. Genetic variability in the G protein gene of human respiratory syncytial virus isolated from the Campinas metropolitan region, Brazil. J Med Virol. 2008; 80:1653–60.
9. Yun MR, Kim AR, Lee HS, Kim DW, Lee WJ, Kim K, et al. Complete genome sequences of human respiratory syncytial virus genotype a and B isolates from South Korea. Genome Announc. 2015 Apr; 23:3. (2):pii: e00332-15.https://doi.org/10.1128/genomeA.00332-15.
crossref
10. Zhang H, Gao S, Lercher MJ, Hu S, Chen WH. EvolView, an online tool for visualizing, annotating and managing phylogenetic trees. Nucleic Acids Res. 2012; 40(Web Server issue):W569–72.
crossref
11. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, Stone Y, et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985; 151:626–33.
crossref
12. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459:1122–5.
crossref
13. Trento A, Galiano M, Videla C, Carballal G, García-Barreno B, Melero JA, et al. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol. 2003; 84(Pt 11):3115–20.
crossref
14. Trento A, Casas I, Calderón A, Garcia-Garcia ML, Calvo C, Perez-Breña P, et al. Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol. 2010; 84:7500–12.
crossref
15. Hwang SJ, Park DJ, Gu PT, Koo HS, Lee MO. Characteristics of respiratory syncytial virus isolated from acute respiratory infectious disease in Busan. J Bacteriol Virol. 2016; 46:173–80.
crossref
16. Baek YH, Choi EH, Song MS, Pascua PN, Kwon HI, Park SJ, et al. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch Virol. 2012; 157:1039–50.
crossref
17. Eshaghi A, Duvvuri VR, Lai R, Nadarajah JT, Li A, Patel SN, et al. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One. 2012; 7:e32807.
crossref
18. Johansson C. Respiratory syncytial virus infection: an innate perspective. F1000Res. 2016; 5:2898.
crossref
19. Jeong Y, Hwang JH, Kwon JY, Shin J, Kwon JH, Han K, et al. Prediction of the severity and length of hospital stay in infants with acute bronchiolitis using the severity score. Allergy Asthma Respir Dis. 2016; 4:429–35.
crossref
20. Cha MA, Woo YR, Kim HJ, Kim MS, Ahn YH. Factors associated with obesity of acute bronchiolitis in infants: association of obesity with disease severity. Allergy Asthma Respir Dis. 2015; 3:281–7.
crossref
21. Yoshihara K, Le MN, Okamoto M, Wadagni AC, Nguyen HA, Toizumi M, et al. Association of RSV-A ON1 genotype with increased pediatric acute lower respiratory tract infection in Vietnam. Sci Rep. 2016; 6:27856.
crossref
22. Panayiotou C, Richter J, Koliou M, Kalogirou N, Georgiou E, Christo-doulou C. Epidemiology of respiratory syncytial virus in children in Cy-prus during three consecutive winter seasons (2010-2013): age distribution, seasonality and association between prevalent genotypes and disease severity. Epidemiol Infect. 2014; 142:2406–11.
crossref
23. Tabatabai J, Prifert C, Pfeil J, Grulich-Henn J, Schnitzler P. Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13. PLoS One. 2014; 9:e109191.
crossref

Fig. 1.
Phylogenetic analysis of the RSV-A/RSV-B strains using partial G protein sequences and reference sequences of identified genotypes. All cases are classified into RSV-A, ON1 genotype (n=8) and RSV-B, BA4 genotype (n=1) that are currently circulatin. RSV, respiratory syncytial virus.
aard-6-110f1.tif
Table 1.
Demographic characteristics of the study subjects
Characteristic Group
P-value
Mild (n=44) Severe (n=9)
Age (mo) 2.5 (0.5–4.8) 1.0 (1.0–2.0) 0.011
Length of admission (day) 3.0 (2.3–4.0) 6.0 (4.0–10.0) <0.001
Male sex, n (%) 23 (52) 9 (100) <0.001
Minimum SaO2 at admission (%) 98.0 (97.0–99.0) 83.0 (80.0–92.5) <0.001
BSS 6.0 (5.0–7.0) 13.0 (11.0–14.0) <0.001
VBGA pH 7.37 (7.35–7.42) 7.28 (7.13–7.32) <0.001
VBGA pCO2 (mmHg) 40.8 (35.1–45.6) 62.3 (54.6–95.0) <0.001
VBGA HCO3 (mmol/L) 23.5 (20.9–24.8) 28.2 (25.5–31.2) <0.001
WBCs at admission (×103/mm3) 11.0 (9.09–13.2) 8.1 (7.79–10.1) 0.086
Hemoglobin at admission (g/dL) 11.7 (10.9–12.3) 10.8 (9.8–12.0) 0.128
C-reactive protein at admission (mg/dL) 0.4 (0.0–0.97) 0.3 (0.13–0.52) 0.935

Values are presented as median (interquartile range) unless otherwise indicated.

BSS, bronchiolitis severity score; VBGA, venous blood gas analysis; WBC, white blood cell.

P<0.05.

Table 2.
Clinical characteristics of the study subjects in the severe group
Case Sex Age (day) Length of admission (day) Minimum SaO2 at admission (%) BSS Initial VBGA (pH–pCO2–HCO3#) Ventilator mode RSV (type/genotype) Complications
1 Male 24 9 94 12 7.17–97.4–34.9 Invasive A/ON1 None
2 Male 39 12 8 16 6.73–164.8–21.1 Invasive A/ON1 Mild hypoxic encephalopathy
3 Male 44 6 70 13 7.08–92.6–26.9 Invasive A/ON1 None
4 Male 47 11 91 11 7.23–80.1–32.9 Invasive B/BA4 None
5 Male 54 6 93 14 7.31–59.5–29.4 HFNC A/ON1 None
6 Male 59 4 92 7 7.32–51.6–26.5 HFNC A/ON1 None
7 Male 70 6 90 14 7.31–57.6–28.5 HFNC A/ON1 None
8 Male 71 6 90 11 7.28–62.3–28.2 nCPAP A/ON1 None
9 Male 87 4 90 13 7.36–44.4–24.5 HFNC A/ON1 None

BSS, bronchiolitis severity score; VBGA, venous blood gas analysis; RSV, respiratory syncytial virus; HFNC, heated humidified high flow nasal cannula therapy; nCPAP, nasal continuous positive airway pressure.

pCO2, mmHg.

# HCO3, mmol/L.

TOOLS
Similar articles